// App-Quantinova.ai

398 : Specific skeletal targeting of MMP-2 inhibitors for the treatment of bone metastatic breast cancer

Researchers

Presenter

  • Marilena Tauro

Principal Investigators

  • Antonio Laghezza

  • Paolo Tortorella

  • Conor C. Lynch

Medical Centers

  • University of Bari, Bari, Italy

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Angiogenin

  • Circulating tumor cells

  • DNA Damage Inducible Transcript 3

  • Lactate dehydrogenase

  • Matrix metalloproteinase 2

Drug/Treatment

  • rebastinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved